Abstract
The approach to stroke therapy has historically been limited due to the existence of relatively few treatment options and the necessity for action within 3 hours of symptom onset. As neuroimaging technology advances, fertile new ground is revealed for novel therapies. Recently, a number of exciting mechanical systems have been developed with potential efficacy even hours after cerebrovascular occlusion: endovascular clot disruption, endovascular clot extraction, and angioplasty with stenting are currently under study, with promising initial results. With more options, each with greater effectiveness in a particular clinical scenario, the physician is now better equipped than ever to treat acute ischemic stroke successfully.
Similar content being viewed by others
References and Recommended Reading
Heart Disease and Stroke Statistics — 2006 Update. Dallas, TX: American Heart Association; 2006.
Lattimore SU, Chatela J, Davis L, et al.: Impact of establishing a primary stroke center at a community hospital on the use of thrombolytic therapy; the NINDS suburban hospital stroke center experience. Stroke 2003, 34:e55–e57.
Douglas VC, Tong DC, Gillum LA, et al.: Do the brain attack coalition’s criteria for stroke centers improve care for ischemic stroke? Neurology 2005, 64:422–427.
Wojner-Alexandrov AW, Alexandrov AV, Rodriguez D et al.: Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO). Stroke 2005, 36:1512–1518.
Hjort N, Butcher K, Davis SM, et al.: Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke 2005, 36:388–397.
Warach S, Gaa J, Siewer B, et al.: Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 1995, 37:231–241.
Sorensen AG, Buonanno FS, Gonzalez RG, et al.: Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. Radiology 1996, 199:391–401.
Li F, Han S, Tatlisumak T, et al.: A new method to improve in-bore middle cerebral artery occlusion in rats: demonstration with diffusion-and perfusion-weighted imaging. Stroke 1998, 29:1719–1720.
Hacke W, Albers G, Al-Rawi Y, et al.: The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005, 36:66–73.
Furlan AJ, Eyding D, Albers GW, et al.: Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006, 37:1227–1231.
The National Institute of Neurological Disorders rt-A Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581–1587.
Fagan SC, Morgenstern LB, Petitta A, et al.: Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rtPA Stroke Study Group. Neurology 1998, 50:883–890.
Kwiatkowski TG, Libman RB, Frankel M, et al.: Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Pasminogen Activator Group. N Engl J Med 1999, 340:1781–1787.
Alexandrov AV, Burgin WS, Demchuck AM, et al.: Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement. Circulation 2001, 103:2897–2902.
Rother J, Schellinger PD, Gass A, et al.: Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 h. Stroke 2002, 33:2438–2445.
Nighoghossian N, Hermier M, Adeleine P, et al.: Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator. Stroke 2003, 34:458–463.
Christou I, Burgin WS, Alexandrov AV et al.: Arterial status after intravenous TPA therapy for ischaemic stroke. A need for further interventions. Int Angiol 2001, 20:208–213.
Hacke W, Donnan G, Fieschi C, et al.: Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rtPA stroke trials. Lancet 2004, 363:768–774.
Adams HP Jr, Adams RJ, Brott T, et al.: Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003, 34:1056–1083.
Norris JW, Buchan A, Cote R, et al.: Canadian guidelines for intravenous thrombolytic treatment in acute stroke. A consensus statement of the Canadian Stroke Consortium. Can J Neurol Sci 1998, 25:257–259.
Brainin M, Olsen TS, Chamorro A, et al.: Organization of stroke care: education, referral, emergency management and imaging, stroke units and rehabilitation. European Stroke Initiative. Cerebrovasc Dis 2004, 17(Suppl 2):1–14.
Furlan A, Higashida R, Wechsler L, et al.: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999, 282:2003–2011.
Alvarez-Sabin J, Molina CA, Ribo M, et al.: Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion. Stroke 2004, 35:2493–2498.
Alexandrov AV, Demchuk AM, Felberg RA, et al.: High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial Doppler monitoring. Stroke 2000, 31:610–614.
Barnwell SL, Clark WM, Nguyen TT, et al.: Safety and efficacy of delayed intra-arterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. Am J Neuroradiol 1994, 15:1817–1822.
Sorimachi T, Fujii Y, Tsuchiya N, et al.: Recanalization by mechanical embolus disruption during intra-arterial thrombolysis in the carotid territory. Am J Neuroradiol 2004, 25:1391–1402.
Qureshi AI, Siddiqui AM, Suri MF, et al.: Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 2002, 51:1319–1329.
Mahon BR, Nesbit GM, Barnwell SL, et al.: North American Clinical Experience with the EKOS MicroLysUS Infusion Catheter for the Treatment of Embolic Stroke. AJNR Am J Neuroradiol 2003, 24:534–538.
Soltani A, Soliday C: Effect of ultrasound on enzymatic activity of selected plasminogen activators. Thromb Res 2006, In press.
Alexandrov AV, Molina CA, Grotta JC, et al.: Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004, 351:2170–2178.
Daffertshofer M, Gass A, Ringleb P, et al.: Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischaemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a Phase II clinical trial. Stroke 2005, 36:1441–1446.
Berlis A, Lutsep H, Barnwell S, et al.: Mechanical thrombolysis in acute ischemic stroke with endovascular photoacoustic recanalization. Stroke 2004, 35:1112–1116.
Vallee JN, Crozier S, Guillevin R, et al.: Acute basilar artery occlusion treated by thromboaspiration in a cocaine and ecstasy abuser. Neurology 2003, 61:839–841.
Lutsep HL, Clark WM, Nesbit GM, et al.: Intraarterial suction thrombectomy in acute stroke. Am J Neuroradiol 2002, 23:783–786.
Kapoor BS, Rathman G, Shrawny S: Retrieving a malpositioned tracheobronchial stent utilizing Amplatz gooseneck snare: a case report. Cardiovasc Intervent Radiol 2004, 27:391–393.
Fourie P, Duncan IC.: Microsnare-assisted mechanical removal of intraprocedural distal middle cerebral arterial thromboembolism. Am J Neuroradiol 2003, 24:630–632.
Schumacher HC, Meyers PM, Yavagal DR, et al.: Endovascular mechanical thrombectomy of an occluded superior division branch of the left mca for acute cardioembolic stroke. Cardiovasc Intervent Radiol 2003, 26:305–308.
Nesbit GM, Luh G, Tien R, Barnwell SL: New and future endovascular treatment strategies for acute ischemic stroke. J Vasc Interv Radiol 2004, 15(1 Pt 2):S103–S110.
Mayer TE, Hamann GF, Brueckman HJ: Treatment of basilar artery embolism with a mechanical extraction device. Stroke 2002, 33:2232–2235.
Pierre-Gobin Y, Starkman S, Duckwiler GR, et al.: MERCI 1. A Phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 2004, 35:2848–2854.
Smith W, Sung G, Starkman S, et al.: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005, 36:1432–1441.
Smith WS: Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. Am J Neuroradiol 2006, 27:1177–1182.
Schumacher HC, Khaw AV, Meyers PM, et al.: Intracranial angioplasty and stent placement for cerebral atherosclerosis. J Vasc Interv Radiol 2004, 15(1 Pt 2):S123–S132.
Ringer AJ, Qureshi AI, Fessler RD, et al.: Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischaemic stroke. Neurosurgery 2001, 48:1282–1288.
Qureshi AI, Siddiqui AM, Kim SH, et al.: Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. Am J Neuroradiol 2004, 25:322–328.
Nakano S, Iseda T, Yoneyama T, et al.: Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: an alternative option to intra-arterial thrombolysis. Stroke 2002, 33:2872–2876.
Phatouros CC, Higashida RT, Malek AM, et al.: Endovascular stenting of an acutely thrombosed basilar artery: technical case report and review of the literature. Neurosurgery 1999, 44:667–673.
SSYLVIA Investigators: Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA) study results. Stroke 2004, 35:1388–1392.
Boston Scientific: Available at http://www.bostonscientific.com/. Accessed August 15, 2006.
Cruz-Flores S, Diamond A: Angioplasty for intracranial artery stenosis. Cochrane Database Syst Rev 2006.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fussell, D., Schumacher, H.C., Meyers, P.M. et al. Mechanical interventions to treat acute stroke. Curr Neurol Neurosci Rep 7, 21–27 (2007). https://doi.org/10.1007/s11910-007-0017-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11910-007-0017-3